To improve the quality of healthcare by providing innovative discovery, development and manufacturing solutions to enable superior therapeutic options for patients
To be the preferred provider of specialist services and proprietary technologies to enable the development and commercialisation of better biopharmaceuticals products
To actively engage with innovators to accelerate the development process for innovative and differentiated products
To sustain a strong reputation as an innovator in the field of biopharmaceutical development
Abzena is a revenue generating life sciences group with its headquarters in the UK and two sites in the US. The Group offers a range of complementary services and technologies for the selection, development and manufacture of biopharmaceuticals.About Us
Contact Investor Relations
Our Latest News and Events
Abzena presents its latest research and exhibits at events all over the world.
Find out where we are next and our latest news below.
Abzena announces a research and licence agreement with Tmunity Therapeutics, a T cell engineering company
Ocean Place Resort, Long Branch, NJ
17 September 2018
Faron Pharmaceuticals Ltd announces that it has filed a Clinical Trial Application (CTA)
Hyatt Regency, New Brunswick, NJ
27 September 2018